SHL Telemedicine

A Global Leader in Telemedicine Technologies & Services

SHL at a Glance:

Significantly reduces mortality, improves quality of life, and reduces healthcare costs
Develops technologies, solutions, and advanced telemedicine services, for diagnosis and monitoring of the heart and various chronic diseases
A leading telemedicine provider in Israel and Germany with vast experience in remote medical services
24/7 telemedicine centers in Israel and Germany with global services based on cloud technology; about 3 million medical interactions per year
A world leader in personal use hospital-grade mobile 12-lead ECG device, FDA cleared

INTRODUCING

The only mobile hospital grade full 12-lead ECG for personal use (FDA cleared)

SHL TELEMEDICINE is proud to collaborate with MAYO CLINIC, a leading hospital and healthcare services system in the USA and globally

LATEST NEWS

SHL announces 2025 Annual General Meeting Results

For more information, please click here

SHL announces clarification regarding the upcoming Annual General Meeting

For more information, please click here

SHL announces full-year 2024 results

For more information, please click here

SHL announces invitation to an Annual General Meeting

For more information, please click here

SHL discloses write-offs and extraordinary items for full year results 2024

For more information, please click here

SHL acquires remaining stake of Mediton Group

For more information, please click here

Previous

Next

Our Markets

ISRAEL
GERMANY
USA

ISRAEL

B2C model – sale of cardiac monitoring services to consumers: personal 12-Lead ECG device for transmission of remote medical data, 24/7 telemedicine center, electronic personal medical record, Mobile Intensive Care Units in coverage areas.

Large Subscribers base with long term memberships
Steady cash flow with growth potential

Growth engines in Israel

Implementation of the SmartHeart with wide audiencess
Combining Big-Data Technology and Artificial-Intelligence from International Medical Institutions for Preventive Medicine and Early Detection
Expanding collaborations with Sick Funds

To the Israeli website

GERMANY

SHL is the market leader in Germany operating a B2B model – monitors and stabilizes chronic patients and saves costs for the Sick Funds
The Company has agreements with leading Sick funds covering about 25% of the German health insurance market (about 20 million insured)

Growth engines in Germany supported by legislation:

Additional agreements for monitoring chronic patients with the potential for doubling existing activity
Agreements for providing Virtual Visits – penetrating a market of about 800 million doctors’ visits per year

To the German website

USA

B2B2C growth through strategic collaborations with leading healthcare industry partners

The goal: not to send the patient to the ECG, but send the ECG to the patient – remote cardiac monitoring, using SmartHeart technology

Collaboration with Mayo Clinic, a US tier 1 medical institution, to provide patients with SmartHeart when they are discharged from the hospital
Implementing ECG technology combining Big-Data and Artificial-Intelligence technologies
Use of SmartHeart technology in the US has already started and is being used daily in clinics and home visits
OTC for Smartheart – pre-submission with FDA for Over the Counter clearance of SHL’s SmartHeart™ full 12 Lead ECG was filed in January 2021

UNIQUE ADVANCED TECHNOLOGY

Cloud-based patented technology

The only solution to perform a full 12-Lead personal ECG without assistance from a medical professional from anywhere in the world at any time within 30 seconds

SOLUTIONS & PRODUCTS

TELEMEDICINE PRODUCT

TelePress™

The TelePress™ is a comprehensive remote blood pressure monitoring device for personal use. By placing a strap around the upper arm and pressing a button, a person easily activates the automatic measurement and transmission of the heart rate and blood pressure readings to a remote medical monitoring center. These values are then compared to baseline measurements and added to the corresponding personal health record, which is stored in a central database. The home-based, one-touch, automatic self-pressurization device accurately measures the heart rate, systolic and diastolic values, which are displayed on a large LCD screen. Storage, evaluation, and transmission of measured values are handled by the HCC IV. Features / Advantages Real-Time response to abnormal measurements Early identification of unfavorable …

The TelePress™ is a comprehensive remote blood pressure monitoring device for personal use. By placing a strap around the upper arm and pressing a button, a person easily activates the automatic measurement and transmission of the heart rate and blood pressure readings to a remote medical monitoring center. These values are then compared to baseline measurements and added to the corresponding personal health record, which is stored in a central database.

The home-based, one-touch, automatic self-pressurization device accurately measures the heart rate, systolic and diastolic values, which are displayed on a large LCD screen. Storage, evaluation, and transmission of measured values are handled by the HCC IV.

Features / Advantages

Real-Time response to abnormal measurements
Early identification of unfavorable trends
Personal monitoring program
Improved management of treatment programs
Assured access to accurate patient data

TELEMEDICINE PRODUCT

CCM™

SHL Telemedicine’s Central Communication Module (CCM™) is an innovative telecommunication device that transmits medical data to our telemedicine centers from a variety of medical monitoring devices developed by SHL.The SHL CCM is designed to transmit over an Internet connection, cellular platform, or regular landline. The choice of transmission method will depend on the type of telemedicine device/s provided to the user and their telecommunication set up at home.Our CCM works with many devices from SHL’s product line, including our blood pressure, weighing (TeleWeight), oxygen saturation level (TelePulse Oximeter), breath exhalation (TeleBreather™) and sugar measuring devices. The CCM is a compact “plug and play” device. It has no control buttons, as there is no need for user intervention.SHL can configure …

SHL Telemedicine’s Central Communication Module (CCM™) is an innovative telecommunication device that transmits medical data to our telemedicine centers from a variety of medical monitoring devices developed by SHL.

The SHL CCM is designed to transmit over an Internet connection, cellular platform, or regular landline. The choice of transmission method will depend on the type of telemedicine device/s provided to the user and their telecommunication set up at home.

Our CCM works with many devices from SHL’s product line, including our blood pressure, weighing (TeleWeight), oxygen saturation level (TelePulse Oximeter), breath exhalation (TeleBreather™) and sugar measuring devices. The CCM is a compact “plug and play” device. It has no control buttons, as there is no need for user intervention.

SHL can configure the device and update the software remotely.

The CCM encrypts and automatically transmits the data measured by the connected device to the monitoring center for storage in the user’s personal health record. If the values deviate from the patient’s individual thresholds, an alarm will be triggered causing the medical staff at the monitoring center to contact the patient to establish what might have triggered the deviation. They will then assess and take the steps necessary to bring the individual back to acceptable values. This is an essential component of our chronic disease monitoring solution and one that keeps our users in more stable condition than they would be if left to cope on their own.

IEC 60601-1-2 Manufacturer Declaration

TELEMEDICINE PRODUCT

Cardio’B™

SHL introduces a new portable device to transmit a 12-lead ECGAdvancements in ergonomics bring you the Cardio’B™, the lightest device of its kind, for ECG transmissions from the comfort of your home, office and on the go. The Cardio’B™ is an exclusive design by SHL and differentiates itself through usability and easy handling and provides a clear and noiseless ECG transmission.Cardio’B™ features:ECG is transmitted acoustically to the Telemedicine monitoring center via any type of phone connection, including regular fixed lines and cellular phones.Easy handling and usabilityWith the simple press of a button the transmission is passed on. It takes less than a minute to send a full ECG transmission to the Telemedicine monitoring center.Advanced ergonomicsMeticulously applied ergonomics allow for …

SHL introduces a new portable device to transmit a 12-lead ECG

Advancements in ergonomics bring you the Cardio’B™, the lightest device of its kind, for ECG transmissions from the comfort of your home, office and on the go. The Cardio’B™ is an exclusive design by SHL and differentiates itself through usability and easy handling and provides a clear and noiseless ECG transmission.

Cardio’B™ features:
ECG is transmitted acoustically to the Telemedicine monitoring center via any type of phone connection, including regular fixed lines and cellular phones.

Easy handling and usability
With the simple press of a button the transmission is passed on. It takes less than a minute to send a full ECG transmission to the Telemedicine monitoring center.

Advanced ergonomics
Meticulously applied ergonomics allow for easy and comfortable handling. The slick design and low weight make the Cardio’B™ truly unique among its kind. The ergonomic design ensures that the electrodes are kept effortlessly in close contact with the body throughout the entire transmission.
The electrode belt is made of elastic materials to provide a pleasant feeling. The elastic belt, which surrounds the upper body section, is attached to the front of the device and is easy to mount and adjust.
The Cardio’B™ is suitable for both spouses. Setting of the relevant user is done via an easy selection process.

The Cardio’B™ is a registered trademark of SHL Telemedicine.

IEC 60601-1-2 Manufacturer Declaration

TELEMEDICINE PRODUCT

SmartHeart®

The smartheart™ is the first and only personal mobile 12-lead ECG device on the market that enables the detection of heart attacks. It’s also the smallest 12-lead ECG in the world. In fact, it’s not much bigger than your smartphone.

With smartheart and a smartphone or tablet (iPhone, iPad, Android, etc.), you can perform a full hospital grade ECG without any need for medical professional assistance, and send it to your physician, clinic or hospital for diagnosis. …

SmartHeart is an FDA cleared hospital-grade 12-lead ECG device, fast, user-friendly, reliable. SmartHeart can be applied by a physician or the patient to perform a full 12-lead ECG. The SHL telemedicine centers professional medical staff are avaialble for you 24/7, will review the ECGs and provide you findings.

SmartHeartPro© data is stored in the cloud. It is secured and HIPAA compliant, so you know your patients’ privacy meets rigorous security standards

SmartHeartPro© has proven its value in busy physician practices and has revolutionized the ECG experience. Replacing cumbersome and expensive generation ECG machines, or the need to send patients elsewhere for ECG. With SmartHeartPro© you’ll be able to continue providing your patients the best experience while increasing efficiency in your practice.

We are confident that once you’ve tried SmartHeartPro©, you will never switch back to the traditional ECG machine. You can also sign up and benefit from our professional medical support 24/7. The SHL Telemedicine center will review the ECG and provide findings to allow you quicker and efficient analysis of ECGs.

The SmartHeartPro© platform enables you to use the most advanced technology and the expertise of SHL telemedicine centers’ staff, who review ECGs and return their ECG report with findings, with a turnaround time of no longer than 15 minutes.

TELEMEDICINE PRODUCT

CardioSen’C™

The TelePress™ is a comprehensive remote blood pressure monitoring device for personal use. By placing a strap around the upper arm and pressing a button, a person easily activates the automatic measurement and transmission of the heart rate and blood pressure readings to a remote medical monitoring centre. These values are then compared to baseline measurements and added to the corresponding personal health record , which is stored in a central database. The home-based, one-touch, automatic self-pressurization device accurately measures the heart rate, systolic and diastolic values, which are displayed on a large LCD screen. Storage, evaluation, and transmission of measured values are handled by the HCC IV. …

Breakthrough innovative Technology, CardioSen’C™, the first personal cellular-digital 12-lead ECG transmitter.

The CardioSen’C™ transmits a patient’s complete 12-lead ECG and rhythm read-out strip in real-time to support professional evaluation of medical conditions such as arrhythmia, ischemia, and myocardial infarction.

The CardioSen’C™ is a cellular-digital 12-lead ECG transmitter device for personal use, which reliably transmits a patient’s 12-lead ECG, directly to SHL’s medical monitoring center, for remote and real-time evaluation of arrhythmia, ischemia, and myocardial infarction conditions. The received ECG is analyzed by SHL’s on-call medical professional team. Together with the clinical description, provided by the in distress person, the medical team possesses the necessary data to evaluate the situation and provide medical assistance if necessary. SHL’s advanced Telemedicine service can help to drastically reduce morbidity and mortality rates following an acute myocardial infarction or other severe cardiac incidents.

Features

Simultaneous real-time 12-lead ECG sampling (only 3 seconds) for improved quality and faster rate of transmission.
Transmission of digital encoded ECG data, through a built-in cellular modem, allows for maximal ECG accuracy, due to the elimination of typical background noises, which are present when using acoustic transmission via common telephone lines.
If there is no cellular reception, the device transmits the ECG acoustically.
Enables medical professionals at the medical monitoring center to remotely operate and control the device. This promises a calm, clear and effortless transmission on the part of the user.
Innovative design with advanced ergonomics, which includes an LCD display and vocal guidance.
New electrode design for enhanced contact and conductivity.

* SHL-brand FDA certified heart care devices include the Cardiobeeper™, Cardiobeeper 12L™ and the CardioPocket™.
CardioSen’C (CardioSenc) is a registered Trademark of SHL Telemedicine

cardiac monitoring product innovation of the year award

IEC 60601-1-2 Manufacturer Declaration

Share InFORMATION

SIX: SHLTN
NASDAQ: SHLT

Stock Info

Ticker Symbol : SHLTN

Listed on SIX Swiss Exchange

Currency : CHF

Swiss Security Number : 1128957,ISIN IL10855885

View stock info

Stock Quote

There may be a slight delay in refreshing the data. You can find the updated numbers here

Stock Info

Ticker Symbol : SHLT

Listed on Nasdaq

Currency : USD

Security Number: 78423T200, ISIN US78423T2006

View stock info

Stock Quote

There may be a slight delay in refreshing the data. You can find the updated numbers here

Stock Info

Ticker Symbol : SHLTN

Listed on SIX Swiss Exchange

Currency : CHF

Swiss Security Number : 1128957,ISIN IL10855885

View stock info

Stock Quote

There may be a slight delay in refreshing the data. You can find the updated numbers here

OUR PARTNERS

EMPLOYEE STORIES

COMMITTED, EXPERIENCED AND TRUSTING: OUR TEAM

Dr. Itamar Offer

Chairman of the Board

DAVID ARNON

Lior Haalman

BERND ALTPETER

IDO NOUBERGER

NIR ROTENBERG

Previous

Next

SHL HEADQUARTERS

EUROPE

USA

Subscribe for News and Updates

Powered by

FatFish - web & mobile design and development